Truist Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
CIA
CAI
SIC
KA
SSWG
CL
MCM
AF
Truist Financial's IBDX Position: Q2 2026 in Review
Truist Financial reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 0.75% in Q2 2026, selling an estimated $2.37K and leaving 12,383 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.
Truist Financial first reported a position in IBDX in Q4 2023 and has held it in 8 quarters since. The position peaked at $539K in Q2 2024. 150 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Truist Financial held 12,383 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $312K as of Q2 2026.
- Truist Financial sold 94 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.37K.
- iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2517 holding.
- Truist Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 8 quarters since.
- Truist Financial's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $539K in Q2 2024.
- 150 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.